AW
RVMD icon

Avion Wealth’s Revolution Medicines RVMD Stock Holding History

Avion Wealth’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10K Buy
55
+13
+31% +$1.9K ﹤0.01% 611
2026
Q1 		$4K Buy
42
+20
+91% +$2.02K ﹤0.01% 730
2025
Q4 		$1K Buy
22
+6
+38% +$393 ﹤0.01% 1122
2025
Q3 		$0 Sell
16
-53
-77% -$2.08K ﹤0.01% 1496
2025
Q2 		$2K Buy
+69
New +$2.65K ﹤0.01% 853
2024
Q3 		– Sell
-13
Closed – – 1292
2024
Q2 		$0 Buy
+13
New +$486 ﹤0.01% 1214

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Avion Wealth's RVMD Position: Q2 2026 in Review

Avion Wealth increased its Revolution Medicines (RVMD) stake by 31% in Q2 2026, buying an estimated $1.9K and bringing the position to 55 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

Avion Wealth first reported a position in RVMD in Q2 2024 and has held it in 6 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Avion Wealth held 55 shares of Revolution Medicines worth $10K as of Q2 2026.
  • Avion Wealth bought 13 Revolution Medicines shares in Q2 2026, an estimated $1.9K.
  • Revolution Medicines made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #611 holding.
  • Avion Wealth first reported a position in Revolution Medicines in Q2 2024 and has held it in 6 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.